Rapid Micro Biosystems, Inc. reaffirmed revenue guidance for the full year 2022. For the period, the company expects its prior full year 2022 revenue outlook of at least $17.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.82 USD | -2.26% | 0.00% | +10.81% |
05-03 | Transcript : Rapid Micro Biosystems, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
05-03 | Earnings Flash (RPID) RAPID MICRO BIOSYSTEMS Posts Q1 Revenue $5.6M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.81% | 35.96M | |
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+2.12% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B |
- Stock Market
- Equities
- RPID Stock
- News Rapid Micro Biosystems, Inc.
- Rapid Micro Biosystems, Inc. Reaffirms Revenue Guidance for the Full Year 2022